These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 8047081

  • 1. Survival in medically treated patients with homozygous beta-thalassemia.
    Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A, Martin M, Koren G, Cohen AR.
    N Engl J Med; 1994 Sep 01; 331(9):574-8. PubMed ID: 8047081
    [Abstract] [Full Text] [Related]

  • 2. Longitudinal study of survival and causes of death in patients with thalassemia major in Greece.
    Ladis V, Chouliaras G, Berdousi H, Kanavakis E, Kattamis C.
    Ann N Y Acad Sci; 2005 Sep 01; 1054():445-50. PubMed ID: 16339695
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major.
    Brittenham GM, Griffith PM, Nienhuis AW, McLaren CE, Young NS, Tucker EE, Allen CJ, Farrell DE, Harris JW.
    N Engl J Med; 1994 Sep 01; 331(9):567-73. PubMed ID: 8047080
    [Abstract] [Full Text] [Related]

  • 4. Intensification of chelating-therapy in patients with thalassemia major.
    Laws HJ, Göbel U, Christaras A, Janssen G.
    Klin Padiatr; 2005 Sep 01; 217(3):120-5. PubMed ID: 15858702
    [Abstract] [Full Text] [Related]

  • 5. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.
    Shalitin S, Carmi D, Weintrob N, Phillip M, Miskin H, Kornreich L, Zilber R, Yaniv I, Tamary H.
    Eur J Haematol; 2005 Feb 01; 74(2):93-100. PubMed ID: 15654898
    [Abstract] [Full Text] [Related]

  • 6. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.
    Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi R, Piga A, Cnaan A.
    Haematologica; 2004 Oct 01; 89(10):1187-93. PubMed ID: 15477202
    [Abstract] [Full Text] [Related]

  • 7. Survival and complications of beta-thalassemia in Lebanon: a decade's experience of centralized care.
    Charafeddine K, Isma'eel H, Charafeddine M, Inati A, Koussa S, Naja M, Taher A.
    Acta Haematol; 2008 Oct 01; 120(2):112-6. PubMed ID: 19001806
    [Abstract] [Full Text] [Related]

  • 8. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
    Chirico V, Rigoli L, Lacquaniti A, Salpietro V, Piraino B, Amorini M, Salpietro C, Arrigo T.
    Eur J Haematol; 2015 May 01; 94(5):404-12. PubMed ID: 25200112
    [Abstract] [Full Text] [Related]

  • 9. Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM (Groupe Francophone des Myélodysplasies).
    Rose C, Brechignac S, Vassilief D, Pascal L, Stamatoullas A, Guerci A, Larbaa D, Dreyfus F, Beyne-Rauzy O, Chaury MP, Roy L, Cheze S, Morel P, Fenaux P, GFM (Groupe Francophone des Myélodysplasies).
    Leuk Res; 2010 Jul 01; 34(7):864-70. PubMed ID: 20129667
    [Abstract] [Full Text] [Related]

  • 10. [Evaluation of heart and liver iron deposition status in patients with β- thalassemia intermedia and major with MRI T2* technique].
    Li CG, Liu SX, Mai HR, Wang Y, Wen FQ, Liu RY, Zhang XH, Chu WC, Au WY.
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Feb 01; 14(2):110-3. PubMed ID: 22357467
    [Abstract] [Full Text] [Related]

  • 11. Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major.
    Wolfe L, Olivieri N, Sallan D, Colan S, Rose V, Propper R, Freedman MH, Nathan DG.
    N Engl J Med; 1985 Jun 20; 312(25):1600-3. PubMed ID: 4000198
    [Abstract] [Full Text] [Related]

  • 12. Insulin resistance and beta cell function in chronically transfused patients of thalassemia major.
    Suvarna J, Ingle H, Deshmukh CT.
    Indian Pediatr; 2006 May 20; 43(5):393-400. PubMed ID: 16735760
    [Abstract] [Full Text] [Related]

  • 13. Effect of age at the start of iron chelation therapy on gonadal function in beta-thalassemia major.
    Bronspiegel-Weintrob N, Olivieri NF, Tyler B, Andrews DF, Freedman MH, Holland FJ.
    N Engl J Med; 1990 Sep 13; 323(11):713-9. PubMed ID: 2388669
    [Abstract] [Full Text] [Related]

  • 14. Liver biopsy results in patients with sickle cell disease on chronic transfusions: poor correlation with ferritin levels.
    Karam LB, Disco D, Jackson SM, Lewin D, McKie V, Baker RD, Baker SS, Laver JH, Nietert PJ, Abboud MR.
    Pediatr Blood Cancer; 2008 Jan 13; 50(1):62-5. PubMed ID: 17457853
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of survival in medically treated patients with homozygous beta thalassemia by the quick hit method.
    Iacovino JR.
    J Insur Med; 2008 Jan 13; 26(4):403-4. PubMed ID: 10150804
    [Abstract] [Full Text] [Related]

  • 16. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy.
    Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C, Andreani M, Agostinelli F, Albertini F, Clift RA.
    N Engl J Med; 1993 Sep 16; 329(12):840-4. PubMed ID: 8355742
    [Abstract] [Full Text] [Related]

  • 17. Survival and complications in thalassemia.
    Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, Ghilardi R, Origa R, Piga A, Romeo MA, Zhao H, Cnaan A.
    Ann N Y Acad Sci; 2005 Sep 16; 1054():40-7. PubMed ID: 16339650
    [Abstract] [Full Text] [Related]

  • 18. Serum ferritin concentrations in transfusion dependent beta-thalassaemia.
    George E, Wong HB, George R, Ariffin WA.
    Singapore Med J; 1994 Feb 16; 35(1):62-4. PubMed ID: 8009283
    [Abstract] [Full Text] [Related]

  • 19. [The mechanism of cataract formation in persons with beta-thalassemia].
    Popescu C, Siganos D, Zanakis E, Padakis A.
    Oftalmologia; 1998 Feb 16; 45(4):10-3. PubMed ID: 10418622
    [Abstract] [Full Text] [Related]

  • 20. Growth velocity in transfusion dependent prepubertal thalassemia patients: results from a thalassemia center in Malaysia.
    Hamidah A, Arini MI, Zarina AL, Zulkifli SZ, Jamal R.
    Southeast Asian J Trop Med Public Health; 2008 Sep 16; 39(5):900-5. PubMed ID: 19058587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.